曼恩凯德生物医疗(MNKD)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MNKD 曼恩凯德生物医疗

交易中 07-24 15:17:12 EDT

5.83

-0.06

-0.95%

最高5.92	最低5.79	成交量132.60万
今开5.81	昨收5.89	日振幅2.21%
总市值15.89亿	流通市值15.52亿	总股本2.72亿
成交额777.89万	换手率0.50%	流通股本2.66亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"MNKD","market":"US","secType":"STK","nameCN":"曼恩凯德生物医疗","latestPrice":5.8339,"timestamp":1721848630177,"preClose":5.89,"halted":0,"volume":1326012,"delay":0,"floatShares":265969933,"shares":272315846,"eps":0.031595,"marketStatus":"交易中","marketStatusCode":2,"change":-0.0561,"latestTime":"07-24 15:17:12 EDT","open":5.81,"high":5.92,"low":5.79,"amount":7778922.763854,"amplitude":0.022071,"askPrice":5.84,"askSize":3109,"bidPrice":5.83,"bidSize":1236,"shortable":3,"etf":0,"ttmEps":0.031595,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1721851200000},"adr":0,"listingDate":1090987200000,"adjPreClose":5.89,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":5.9,"preClose":5.89,"latestTime":"08:47 EDT","volume":2655,"amount":15653.669724,"timestamp":1721825278384},"postHourTrading":{"tag":"盘后","latestPrice":5.99,"preClose":5.89,"latestTime":"19:58 EDT","volume":87120,"amount":513546.7261,"timestamp":1721779125813},"volumeRatio":0.582478,"impliedVol":0.4293,"impliedVolPercentile":0.3532},"requestUrl":"/m/hq/s/MNKD/wiki","defaultTab":"wiki","newsList":[{"id":"2450836360","title":"曼恩凯德生物医疗盘中异动 急速上涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450836360","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450836360?lang=zh_cn&edition=full","pubTime":"2024-07-09 00:49","pubTimestamp":1720457342,"startTime":"0","endTime":"0","summary":"北京时间2024年07月09日00时49分，曼恩凯德生物医疗股票出现波动，股价急速上涨5.07%。截至发稿，该股报5.39美元/股，成交量91.9796万股，换手率0.34%，振幅4.48%。机构评级方面，在所有5家参与评级的机构中，80%的券商给予买入建议，20%的券商给予持有建议，无券商给予卖出建议。曼恩凯德生物医疗股票所在的生物技术行业中，整体涨幅为0.90%。曼恩凯德生物医疗公司简介：MannKind Corp是一家生物制药公司。该产品由小型便携式吸入器提供的人胰岛素干粉制剂组成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709004902af911af4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709004902af911af4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4584","BK4139","MNKD"],"gpt_icon":0},{"id":"2446529004","title":"曼恩凯德生物医疗盘中异动 快速拉升5.19%报5.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446529004","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446529004?lang=zh_cn&edition=full","pubTime":"2024-06-25 00:43","pubTimestamp":1719247401,"startTime":"0","endTime":"0","summary":"北京时间2024年06月25日00时43分，曼恩凯德生物医疗股票出现波动，股价大幅上涨5.19%。截至发稿，该股报5.38美元/股，成交量186.988万股，换手率0.69%，振幅5.17%。曼恩凯德生物医疗股票所在的生物技术行业中，整体涨幅为1.89%。曼恩凯德生物医疗公司简介：MannKind Corp是一家生物制药公司。该产品由小型便携式吸入器提供的人胰岛素干粉制剂组成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625004321968164b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625004321968164b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4584","BK4139","MNKD"],"gpt_icon":0},{"id":"2443670005","title":"曼恩凯德生物医疗盘中异动 股价大跌5.06%报4.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2443670005","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443670005?lang=zh_cn&edition=full","pubTime":"2024-06-15 00:33","pubTimestamp":1718382828,"startTime":"0","endTime":"0","summary":"北京时间2024年06月15日00时33分，曼恩凯德生物医疗股票出现波动，股价快速下跌5.06%。截至发稿，该股报4.79美元/股，成交量90.532万股，换手率0.33%，振幅4.17%。曼恩凯德生物医疗股票所在的生物技术行业中，整体跌幅为0.01%。曼恩凯德生物医疗公司简介：MannKind Corp是一家生物制药公司。消息层面，截至00时33分，《Rodman & Renshaw首予曼恩凯德生物医疗买入评级，目标价8美元》资讯为影响曼恩凯德生物医疗的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240615003349968145a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240615003349968145a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MNKD","BK4584"],"gpt_icon":0},{"id":"2443639506","title":"曼恩凯德生物医疗盘中异动 下午盘大幅上涨5.18%报4.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2443639506","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443639506?lang=zh_cn&edition=full","pubTime":"2024-06-14 01:11","pubTimestamp":1718298669,"startTime":"0","endTime":"0","summary":"北京时间2024年06月14日01时11分，曼恩凯德生物医疗股票出现异动，股价快速拉升5.18%。截至发稿，该股报4.98美元/股，成交量105.602万股，换手率0.39%，振幅5.07%。曼恩凯德生物医疗股票所在的生物技术行业中，整体跌幅为0.07%。曼恩凯德生物医疗公司简介：MannKind Corp是一家生物制药公司。消息层面，截至01时11分，《Rodman & Renshaw首予曼恩凯德生物医疗买入评级，目标价8美元》资讯为影响曼恩凯德生物医疗的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614011109968140f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614011109968140f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MNKD","BK4139","BK4584"],"gpt_icon":0},{"id":"2442847657","title":"曼恩凯德生物医疗盘中异动 早盘股价大跌5.14%报4.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2442847657","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442847657?lang=zh_cn&edition=full","pubTime":"2024-06-10 21:48","pubTimestamp":1718027313,"startTime":"0","endTime":"0","summary":"北京时间2024年06月10日21时48分，曼恩凯德生物医疗股票出现波动，股价快速下跌5.14%。截至发稿，该股报4.43美元/股，成交量35.9463万股，换手率0.13%，振幅3.21%。最近的财报数据显示，该股实现营业收入66.26百万美元，净利润10.63百万美元，每股收益0.04美元，毛利47.67百万美元，市盈率111.38倍。曼恩凯德生物医疗股票所在的生物技术行业中，整体跌幅为0.48%。曼恩凯德生物医疗公司简介：MannKind Corp是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240610214834aef42baf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240610214834aef42baf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MNKD","BK4139","BK4584"],"gpt_icon":0},{"id":"2436602047","title":"曼恩凯德生物医疗2024财年第一财季实现净利润10.63百万美元，同比增加208.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2436602047","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2436602047?lang=zh_cn&edition=full","pubTime":"2024-05-17 00:24","pubTimestamp":1715876660,"startTime":"0","endTime":"0","summary":"3月31日，曼恩凯德生物医疗公布财报，公告显示公司2024财年第一财季净利润为10.63百万美元，同比增加208.47%；其中营业收入为66.26百万美元，同比增加63.08%，每股基本收益为0.04美元。从资产负债表来看，曼恩凯德生物医疗总负债7.11亿美元，其中短期债务32.24百万美元，资产负债比为0.68，流动比率为0.04。机构评级：截至2024年3月31日，当前有5家机构对曼恩凯德生物医疗目标价做出预测，其中目标均价为7.00美元，其中最低目标价为5.00美元，最高目标价为10.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051700242287713ae3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051700242287713ae3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MNKD"],"gpt_icon":0},{"id":"2434013000","title":"曼恩凯德生物医疗盘中异动 早盘快速下挫5.00%报4.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434013000","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434013000?lang=zh_cn&edition=full","pubTime":"2024-05-09 21:47","pubTimestamp":1715262453,"startTime":"0","endTime":"0","summary":"北京时间2024年05月09日21时47分，曼恩凯德生物医疗股票出现异动，股价大幅跳水5.00%。截至发稿，该股报4.18美元/股，成交量30.0423万股，换手率0.11%，振幅8.18%。机构评级方面，在所有5家参与评级的机构中，80%的券商给予买入建议，20%的券商给予持有建议，无券商给予卖出建议。曼恩凯德生物医疗股票所在的生物技术行业中，整体涨幅为0.14%。曼恩凯德生物医疗公司简介：MannKind Corp是一家生物制药公司。该产品由小型便携式吸入器提供的人胰岛素干粉制剂组成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050921473387e86ca1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050921473387e86ca1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MNKD","BK4139","BK4584"],"gpt_icon":0},{"id":"2433267594","title":"MannKind Corp   预计每股收益3美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2433267594","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433267594?lang=zh_cn&edition=full","pubTime":"2024-05-07 10:09","pubTimestamp":1715047773,"startTime":"0","endTime":"0","summary":"   * MannKind公司   预计将在5月8日公布截至2024年3月31日的季度收入报告。* 根据LSEG的数据，5位分析师的平均预期显示，这家总部位于康涅狄格州丹伯里的公司的营收预计将从去年同期的4063万美元增长48.9%，达到6049万美元。* LSEG 分析师对 MannKind 公司的平均预期为每股收益 3 美分。* 华尔街对 MannKind 公司 12 个月目标价的中位数为 6.75 美元，高于其上次收盘价 4.40 美元。5月7日 - 以前季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MNKD"],"gpt_icon":0},{"id":"2432503267","title":"曼恩凯德生物医疗盘中异动 早盘股价大涨5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432503267","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432503267?lang=zh_cn&edition=full","pubTime":"2024-05-01 22:16","pubTimestamp":1714572983,"startTime":"0","endTime":"0","summary":"北京时间2024年05月01日22时16分，曼恩凯德生物医疗股票出现异动，股价急速拉升5.35%。截至发稿，该股报4.33美元/股，成交量18.5415万股，换手率0.07%，振幅4.38%。机构评级方面，在所有5家参与评级的机构中，80%的券商给予买入建议，20%的券商给予持有建议，无券商给予卖出建议。曼恩凯德生物医疗股票所在的生物技术行业中，整体涨幅为0.29%。曼恩凯德生物医疗公司简介：MannKind Corp是一家生物制药公司。该产品由小型便携式吸入器提供的人胰岛素干粉制剂组成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240501221623861ea8a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240501221623861ea8a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MNKD","BK4139","BK4584"],"gpt_icon":0},{"id":"2426413208","title":"曼恩凯德生物医疗盘中异动 股价大跌5.41%报4.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426413208","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2426413208?lang=zh_cn&edition=full","pubTime":"2024-04-10 22:37","pubTimestamp":1712759845,"startTime":"0","endTime":"0","summary":"北京时间2024年04月10日22时37分，曼恩凯德生物医疗股票出现波动，股价急速下挫5.41%。截至发稿，该股报4.20美元/股，成交量50.2422万股，换手率0.19%，振幅2.93%。机构评级方面，在所有6家参与评级的机构中，83%的券商给予买入建议，17%的券商给予持有建议，无券商给予卖出建议。曼恩凯德生物医疗股票所在的生物技术行业中，整体跌幅为1.13%。曼恩凯德生物医疗公司简介：MannKind Corp是一家生物制药公司。该产品由小型便携式吸入器提供的人胰岛素干粉制剂组成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410223725861e4ace&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410223725861e4ace&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MNKD","BK4584","BK4139"],"gpt_icon":0},{"id":"2420286343","title":"曼恩凯德生物医疗盘中异动 下午盘快速拉升5.03%报4.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2420286343","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2420286343?lang=zh_cn&edition=full","pubTime":"2024-03-19 02:11","pubTimestamp":1710785465,"startTime":"0","endTime":"0","summary":"北京时间2024年03月19日02时11分，曼恩凯德生物医疗股票出现异动，股价大幅拉升5.03%。截至发稿，该股报4.70美元/股，成交量110.675万股，换手率0.41%，振幅6.38%。曼恩凯德生物医疗股票所在的生物技术行业中，整体涨幅为0.50%。曼恩凯德生物医疗公司简介：MannKind Corp是一家生物制药公司。消息层面，截至02时11分，曼恩凯德生物医疗股票正面舆情新闻比例100%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403190211067a4d73f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403190211067a4d73f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4584","MNKD"],"gpt_icon":0},{"id":"2418852368","title":"曼恩凯德生物医疗盘中异动 大幅下跌5.12%报5.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2418852368","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2418852368?lang=zh_cn&edition=full","pubTime":"2024-03-11 21:44","pubTimestamp":1710164648,"startTime":"0","endTime":"0","summary":"北京时间2024年03月11日21时44分，曼恩凯德生物医疗股票出现异动，股价快速下挫5.12%。截至发稿，该股报5.00美元/股，成交量38.6183万股，换手率0.14%，振幅4.55%。机构评级方面，在所有6家参与评级的机构中，83%的券商给予买入建议，17%的券商给予持有建议，无券商给予卖出建议。曼恩凯德生物医疗股票所在的生物技术行业中，整体涨幅为0.44%。曼恩凯德生物医疗公司简介：MannKind Corp是一家生物制药公司。该产品由小型便携式吸入器提供的人胰岛素干粉制剂组成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403112144087a4b93f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403112144087a4b93f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MNKD","BK4584"],"gpt_icon":0},{"id":"2417791574","title":"曼恩凯德生物医疗盘中异动 早盘大幅拉升5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2417791574","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2417791574?lang=zh_cn&edition=full","pubTime":"2024-03-08 00:28","pubTimestamp":1709828886,"startTime":"0","endTime":"0","summary":"北京时间2024年03月08日00时28分，曼恩凯德生物医疗股票出现波动，股价急速拉升5.21%。截至发稿，该股报5.05美元/股，成交量385.127万股，换手率1.42%，振幅4.79%。机构评级方面，在所有6家参与评级的机构中，83%的券商给予买入建议，17%的券商给予持有建议，无券商给予卖出建议。曼恩凯德生物医疗股票所在的生物技术行业中，整体涨幅为2.81%。曼恩凯德生物医疗公司简介：MannKind Corp是一家生物制药公司。该产品由小型便携式吸入器提供的人胰岛素干粉制剂组成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030800280779184bb7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030800280779184bb7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MNKD","BK4139","BK4584"],"gpt_icon":0},{"id":"2416962346","title":"曼恩凯德生物医疗2023财年实现净利润-11.94百万美元，同比增加86.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2416962346","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2416962346?lang=zh_cn&edition=full","pubTime":"2024-03-03 00:25","pubTimestamp":1709396712,"startTime":"0","endTime":"0","summary":"12月31日，曼恩凯德生物医疗公布财报，公告显示公司2023财年净利润为-11.94百万美元，同比增加86.34%；其中营业收入为1.99亿美元，同比增加99.46%，每股基本收益为-0.04美元。从资产负债表来看，曼恩凯德生物医疗总负债7.21亿美元，其中短期债务31.98百万美元，资产负债比为0.66，流动比率为3.59。机构评级：截至2023年12月31日，当前有6家机构对曼恩凯德生物医疗目标价做出预测，其中目标均价为7.08美元，其中最低目标价为5.00美元，最高目标价为10.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403030025228afa6638&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403030025228afa6638&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MNKD"],"gpt_icon":0},{"id":"2416564905","title":"曼恩凯德生物医疗盘中异动 早盘急速上涨5.09%报4.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2416564905","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2416564905?lang=zh_cn&edition=full","pubTime":"2024-03-01 22:31","pubTimestamp":1709303481,"startTime":"0","endTime":"0","summary":"北京时间2024年03月01日22时31分，曼恩凯德生物医疗股票出现波动，股价快速拉升5.09%。截至发稿，该股报4.32美元/股，成交量3.6517万股，换手率0.01%，振幅0.73%。曼恩凯德生物医疗股票所在的生物技术行业中，整体涨幅为0.86%。曼恩凯德生物医疗公司简介：MannKind Corp是一家生物制药公司。该产品由小型便携式吸入器提供的人胰岛素干粉制剂组成。消息层面，截至22时31分，曼恩凯德生物医疗股票正面舆情新闻比例20%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240301223121861da8d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240301223121861da8d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4584","MNKD","BK4139"],"gpt_icon":0},{"id":"2416524075","title":"曼恩凯德生物医疗盘中异动 早盘急速拉升5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2416524075","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2416524075?lang=zh_cn&edition=full","pubTime":"2024-02-29 23:17","pubTimestamp":1709219823,"startTime":"0","endTime":"0","summary":"北京时间2024年02月29日23时17分，曼恩凯德生物医疗股票出现异动，股价大幅上涨5.10%。截至发稿，该股报4.12美元/股，成交量60.0537万股，换手率0.22%，振幅3.32%。机构评级方面，在所有6家参与评级的机构中，83%的券商给予买入建议，17%的券商给予持有建议，无券商给予卖出建议。曼恩凯德生物医疗股票所在的生物技术行业中，整体跌幅为1.39%。曼恩凯德生物医疗公司简介：MannKind Corp是一家生物制药公司。该产品由小型便携式吸入器提供的人胰岛素干粉制剂组成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402292317047915fad0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402292317047915fad0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4584","MNKD"],"gpt_icon":0},{"id":"2415784993","title":"曼恩凯德生物医疗盘中异动 股价大涨5.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2415784993","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2415784993?lang=zh_cn&edition=full","pubTime":"2024-02-28 22:31","pubTimestamp":1709130669,"startTime":"0","endTime":"0","summary":"北京时间2024年02月28日22时31分，曼恩凯德生物医疗股票出现波动，股价急速上涨5.82%。截至发稿，该股报4.00美元/股，成交量18.4483万股，换手率0.07%，振幅1.46%。机构评级方面，在所有5家参与评级的机构中，80%的券商给予买入建议，20%的券商给予持有建议，无券商给予卖出建议。曼恩凯德生物医疗股票所在的生物技术行业中，整体跌幅为0.23%。曼恩凯德生物医疗公司简介：MannKind Corp是一家生物制药公司。该产品由小型便携式吸入器提供的人胰岛素干粉制剂组成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022822310987e745e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022822310987e745e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MNKD","BK4584"],"gpt_icon":0},{"id":"2414331515","title":"MannKind 公司报告截至 12 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2414331515","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2414331515?lang=zh_cn&edition=full","pubTime":"2024-02-28 06:43","pubTimestamp":1709073809,"startTime":"0","endTime":"0","summary":"   * MannKind Corp   报告了截至12月底的季度每股盈亏平衡业绩，高于去年同期的每股收益-7美分。华尔街的预期为每股收益-2 美分至 4 美分。* 营收同比增长 62.2%，达到 5847 万美元；分析师预期为 5358 万美元。* MannKind 公司公布的本季度每股收益为盈亏平衡。* 公司报告的季度净收入为 140 万美元。* MannKind Corp 本季度股价下跌了 1.6%。华尔街对 MannKind 公司 12 个月目标价的中位数为 6.75 美元。本摘要由 LSEG 2 月 27 日 10:42 p.m. UTC 数据机器生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MNKD","BK4584"],"gpt_icon":0},{"id":"2414595389","title":"曼恩凯德生物医疗盘中异动 下午盘股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2414595389","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2414595389?lang=zh_cn&edition=full","pubTime":"2024-02-28 02:48","pubTimestamp":1709059708,"startTime":"0","endTime":"0","summary":"北京时间2024年02月28日02时48分，曼恩凯德生物医疗股票出现波动，股价急速拉升5.03%。截至发稿，该股报3.76美元/股，成交量80.8123万股，换手率0.30%，振幅4.75%。机构评级方面，在所有6家参与评级的机构中，83%的券商给予买入建议，17%的券商给予持有建议，无券商给予卖出建议。曼恩凯德生物医疗股票所在的生物技术行业中，整体涨幅为0.22%。曼恩凯德生物医疗公司简介：MannKind Corp是一家生物制药公司。该产品由小型便携式吸入器提供的人胰岛素干粉制剂组成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022802482887e73a9b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022802482887e73a9b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4584","MNKD"],"gpt_icon":0},{"id":"2413749747","title":"MannKind Corp   预计每股盈亏平衡 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2413749747","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2413749747?lang=zh_cn&edition=full","pubTime":"2024-02-24 09:02","pubTimestamp":1708736537,"startTime":"0","endTime":"0","summary":"   * MannKind公司   将于2月27日公布截至2023年12月31日的财报，预计该公司的季度收入将有所增长。* LSEG分析师对MannKind公司的平均预期是每股盈亏平衡。* 华尔街对 MannKind 公司 12 个月目标价的中位数为 6.75 美元，高于上一交易日的收盘价 3.55 美元。2月24日 - 以往季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MNKD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.mannkindcorp.com","stockEarnings":[{"period":"1week","weight":-0.0183},{"period":"1month","weight":0.1526},{"period":"3month","weight":0.4057},{"period":"6month","weight":0.7122},{"period":"1year","weight":0.3296},{"period":"ytd","weight":0.6181}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":0.017},{"period":"3month","weight":0.0957},{"period":"6month","weight":0.1347},{"period":"1year","weight":0.2192},{"period":"ytd","weight":0.1651}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Mannkind Corporation于1991年2月14日在美国特拉华州注册成立。Mannkind Corporation是一家生物制药公司，侧重于诸如糖尿病和癌症之类疗法和药品的开发、研制和推广。该公司的主导候选产品——AFREZZA吸入粉末，是一种超速效胰岛素，处于后期临床研究阶段，用于成人1型或2型糖尿病高血糖的控制治疗。AFREZZA是由该公司的专有技术圈颗粒加载到胰岛素分子里。这些加载的粒子雾化吸入后，会深入到使用AFREZZA吸入器的肺部。糖尿病是一个重大的健康问题。","yearOnYearQuotes":[{"month":1,"riseRate":0.7,"avgChangeRate":0.045334},{"month":2,"riseRate":0.4,"avgChangeRate":-0.004536},{"month":3,"riseRate":0.45,"avgChangeRate":-0.008047},{"month":4,"riseRate":0.4,"avgChangeRate":-0.028112},{"month":5,"riseRate":0.55,"avgChangeRate":0.120551},{"month":6,"riseRate":0.55,"avgChangeRate":0.062891},{"month":7,"riseRate":0.3,"avgChangeRate":-0.059056},{"month":8,"riseRate":0.4,"avgChangeRate":0.002818},{"month":9,"riseRate":0.65,"avgChangeRate":0.078062},{"month":10,"riseRate":0.45,"avgChangeRate":-0.046886},{"month":11,"riseRate":0.45,"avgChangeRate":0.02596},{"month":12,"riseRate":0.55,"avgChangeRate":-0.01539}],"exchange":"NASDAQ","name":"曼恩凯德生物医疗","nameEN":"MannKind"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"曼恩凯德生物医疗(MNKD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供曼恩凯德生物医疗(MNKD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"曼恩凯德生物医疗,MNKD,曼恩凯德生物医疗股票,曼恩凯德生物医疗股票老虎,曼恩凯德生物医疗股票老虎国际,曼恩凯德生物医疗行情,曼恩凯德生物医疗股票行情,曼恩凯德生物医疗股价,曼恩凯德生物医疗股市,曼恩凯德生物医疗股票价格,曼恩凯德生物医疗股票交易,曼恩凯德生物医疗股票购买,曼恩凯德生物医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"曼恩凯德生物医疗(MNKD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供曼恩凯德生物医疗(MNKD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}